Per Lexi:
CrCl ≥15 mL/minute: No dosage adjustment necessary.
CrCl <15 mL/minute: Use is not recommended.
ESRD requiring hemodialysis: No dosage adjustment necessary; administer postdialysis on hemodialysis days.
The only dose reduction I could find is as follows (from UptoDate):
"When TAF is combined within a pharmacokinetic boosting agent (eg,
cobicistat or
ritonavir) as in EVG/c/FTC/TAF, the reduced dose of 10 mg is used. When TAF is not given with a pharmacokinetic booster, as in RPV/FTC/TAF and BIC/FTC/TAF, the dose is 25 mg. Pharmacologic boosting agents (eg, cobicistat, ritonavir) inhibit intestinal P-glycoprotein, thereby increasing TAF bioavailability and tenofovir plasma concentrations; the reduced TAF dose of 10 mg is used to manage this interaction. The long-term safety of TAF at the 25 mg dose given with a pharmacokinetic booster has not been established."
Still, every other day is incorrect.